We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Offers Advice on Potency Assays for Therapeutic Protein COVID-19 Treatments
FDA Offers Advice on Potency Assays for Therapeutic Protein COVID-19 Treatments
The FDA has issued straight-to-final guidance that provides sponsors of monoclonal antibody and other therapeutic protein COVID-19 treatments with recommendations for potency assays to ensure consistent product quality.